DCF Advisers, LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 174 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.

Quarter-by-quarter ownership
DCF Advisers, LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q1 2021$485,000
-51.5%
17,286
-55.1%
0.21%
-48.9%
Q4 2020$1,001,000
-52.3%
38,500
-31.9%
0.41%
-61.5%
Q3 2020$2,100,000
-15.6%
56,500
+16.5%
1.07%
-22.9%
Q2 2020$2,489,000
+258.6%
48,500
+120.5%
1.39%
+206.8%
Q1 2020$694,000
-22.4%
22,000
+46.7%
0.45%
-19.8%
Q4 2019$894,00015,0000.57%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q4 2019
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$27,840,84218.82%
Ikarian Capital, LLC 1,891,147$11,781,8462.84%
Altium Capital Management LP 620,000$3,862,6001.96%
Ikarian Capital, LLC 1,296,900$8,079,6871.95%
Parkman Healthcare Partners LLC 822,784$5,125,9441.36%
Deep Track Capital, LP 4,000,000$24,920,0001.05%
Monaco Asset Management SAM 470,100$2,928,7230.88%
BRAIDWELL LP 3,393,405$21,140,9130.71%
Telemetry Investments, L.L.C. 71,000$4420.70%
Rhenman & Partners Asset Management AB 900,000$5,607,0000.58%
View complete list of ESPERION THERAPEUTICS INC NE shareholders